Good research begins long before papers get written
Autor: | David Thomas Mellor, valda vinson, Chris Graf, Deborah Sweet, Veronique Kiermer, Malcolm R. Macleod, Sowmya Swaminathan, Andrew M Collings |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Open science Medical Sciences media_common.quotation_subject Writing Harmonization Biological Science Disciplines At the National Academies 03 medical and health sciences 0302 clinical medicine Promotion (rank) Political science Openness to experience media_common Multidisciplinary business.industry Reproducibility of Results Public relations Biological Sciences Transparency (behavior) Authorship Scholarly Communication 030104 developmental biology Stewardship business Systemic problem 030217 neurology & neurosurgery Scientific communication |
Zdroj: | Proceedings of the National Academy of Sciences of the United States of America Macleod, M, Collings, A M, Graf, C, Kiermer, V, Mellor, D, Swaminathan, S, Sweet, D & Vinson, V 2021, ' The MDAR (Materials Design Analysis Reporting) Framework for transparent reporting in the life sciences ', Proceedings of the National Academy of Sciences, vol. 118, no. 17, pp. e2103238118 . https://doi.org/10.1073/pnas.2103238118 |
ISSN: | 1476-4687 |
Popis: | Transparency in reporting benefits scientific communication on many levels. While specific needs and expectations vary across fields, the effective interpretation and use of research findings relies on the availability of core information about research materials, study design, data, and experimental and analytical methods. For preclinical research, transparency in reporting is a key focus in response to concerns of replication failure. The inconsistent reporting of key elements of experimental and analytical design, alongside ambiguous description of reagents and lack of access to underlying data and code, has been shown to impair replication (1) and raise doubt about the robustness of results (2, 3). In response to early concerns about replication of published results, funders, publishers, and other stakeholders have called for improvements in reporting transparency (4⇓⇓–7). Several initiatives ensued, including journal policies and joint efforts by journals, funders, and other stakeholders (8⇓–10). One of these initiatives, the Transparency and Openness Promotion (TOP) guidelines (11), outlines a policy framework at the journal level that over 1,000 journals and publishers have adopted. The National Academies have focused on reproducibility and replicability* challenges through several recent initiatives leading to consensus reports, including Reproducibility and Replicability in Science (12), Open Science by Design: Realizing a Vision for 21st Century Research (13), and Fostering Integrity in Research (14). Each of these reports concludes that lack of reporting transparency is one factor which contributes to these systemic problems. Building on these findings, the National Academies convened a public workshop in September 2019 titled “Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting.” The workshop was designed to discuss the current state of transparency in reporting biomedical research and to explore the possibility of improving the harmonization of guidelines across journals and funding agencies. During this workshop, we provided … [↵][1]1To whom correspondence may be addressed: Email: Malcolm.Macleod{at}ed.ac.uk (correspondence regarding the development and evaluation of the guideline) or mellor.david{at}gmail.com (for further information about implementation and stewardship). [1]: #xref-corresp-1-1 |
Databáze: | OpenAIRE |
Externí odkaz: |